$UPST
Upstart Holdings, Inc. Stock $upst

$upst Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000164763923000035 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$135.8M	$102.9M
YoY Change	-40.5%	-66.81%
Cost Of Revenue	$36.80M	$40.59M
YoY Change	-27.94%	-16.15%
Gross Profit	$106.9M	$76.55M
YoY Change	-48.43%	-71.18%
Gross Profit Margin	78.74%	74.37%
Selling, General & Admin	$74.34M	$84.10M
YoY Change	-51.14%	-52.46%
% of Gross Profit	69.54%	109.86%
Research & Development	$57.97M	$110.1M
YoY Change	1.63%	120.18%
% of Gross Profit	54.23%	143.79%
Depreciation & Amortization	$4.400M	$6.441M
YoY Change	91.3%	131.61%
% of Gross Profit	4.12%	8.41%
Operating Expenses	$169.1M	$234.8M
YoY Change	-35.02%	-14.73%
Operating Profit	-$33.34M	-$131.8M
YoY Change	3.85%	-478.48%
Interest Expense	$4.282M	$7.132M
YoY Change	85.13%	643.69%
% of Operating Profit
Other Income/Expense, Net	$5.197M	$2.597M
YoY Change	129.96%	-222.38%
Pretax Income	-$28.10M	-$129.2M
YoY Change	-5.85%	-495.09%
Income Tax	$18.00K	$16.00K
% Of Pretax Income
Net Earnings	-$28.17M	-$129.3M
YoY Change	-5.71%	-495.37%
Net Earnings / Revenue	-20.75%	-125.58%
Basic Earnings Per Share	-$0.34	-$1.58
Diluted Earnings Per Share	-$0.34	-$1.58
COMMON SHARES
Basic Shares Outstanding	82.67M shares	81.39M shares
Diluted Shares Outstanding	83.13M shares	81.91M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$443.7M	$386.9M
YoY Change	-43.87%	-48.94%
Cash & Equivalents	$509.9M	$451.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$489.8M	$429.9M
YoY Change	-41.45%	-46.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$47.01M	$46.98M
YoY Change	30.39%	57.56%
Goodwill	$67.10M	$67.10M
YoY Change	0.0%	0.0%
Intangibles	$13.49M	$14.56M
YoY Change	-24.06%	-22.69%
Long-Term Investments	$41.30M	$41.25M
YoY Change	0.73%	0.61%
Other Assets	$83.80M	$86.95M
YoY Change	-42.76%	-69.36%
Total Long-Term Assets	$1.274B	$1.392B
YoY Change	17.9%	17.84%
TOTAL ASSETS
Total Short-Term Assets	$489.8M	$429.9M
Total Long-Term Assets	$1.274B	$1.392B
Total Assets	$1.764B	$1.822B
YoY Change	-8.0%	-8.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$51.00M	$47.60M
YoY Change	-60.08%	-68.29%
Accrued Expenses	$133.6M	$131.5M
YoY Change	-13.64%	-22.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$184.6M	$179.1M
YoY Change	-34.64%	-44.03%
LONG-TERM LIABILITIES
Long-Term Debt	$930.7M	$1.001B
YoY Change	8.66%	30.11%
Other Long-Term Liabilities	$10.40M	$14.57M
YoY Change	-50.37%	-33.57%
Total Long-Term Liabilities	$941.1M	$1.015B
YoY Change	7.25%	28.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$184.6M	$179.1M
Total Long-Term Liabilities	$941.1M	$1.015B
Total Liabilities	$1.126B	$1.195B
YoY Change	-2.96%	7.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$199.9M	-$171.7M
YoY Change	-389.48%	-273.58%
Common Stock	$8.000K	$8.000K
YoY Change	0.0%	-11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$638.1M	$627.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.764B	$1.822B
YoY Change	-8.0%	-8.35%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$28.17M	-$129.3M
YoY Change	-5.71%	-495.37%
Depreciation, Depletion And Amortization	$4.400M	$6.441M
YoY Change	91.3%	131.61%
Cash From Operating Activities	$162.4M	-$75.73M
YoY Change	-402.74%	-71.62%
INVESTING ACTIVITIES
Capital Expenditures	$2.000M	$1.111M
YoY Change	-128.09%	-31.8%
Acquisitions
YoY Change
Other Investing Activities	-$36.50M	-$20.39M
YoY Change	1193.87%	-294.9%
Cash From Investing Activities	-$38.40M	-$25.85M
YoY Change	286.28%	-599.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-65.90M	$20.97M
YoY Change	89.97%	-74.76%
NET CHANGE
Cash From Operating Activities	162.4M	-$75.73M
Cash From Investing Activities	-38.40M	-$25.85M
Cash From Financing Activities	-65.90M	$20.97M
Net Change In Cash	58.10M	-$80.61M
YoY Change	-159.12%	-54.85%
FREE CASH FLOW
Cash From Operating Activities	$162.4M	-$75.73M
Capital Expenditures	$2.000M	$1.111M
Free Cash Flow	$160.4M	-$76.84M
YoY Change	-444.78%	-71.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	110056000	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001647639
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39797
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Upstart Holdings, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4332431
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2950 S. Delaware Street
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Mateo
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94403
CY2023Q1	dei	City Area Code CityAreaCode	650
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	204-1000
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	UPST
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82670997	shares
CY2022Q4	us-gaap	Cash Cash	422411000	usd
CY2023Q1	us-gaap	Cash Cash	386942000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	64917000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1010421000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	982229000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	18715000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	44168000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46977000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86335000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	83382000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	41250000	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	41250000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	67062000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	67062000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15631000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14562000	usd
CY2022Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	42648000	usd
CY2023Q1	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	44096000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	138720000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	134399000	usd
CY2022Q4	us-gaap	Assets Assets	1936054000	usd
CY2023Q1	us-gaap	Assets Assets	1821720000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1821720000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	6553000	usd
CY2022Q4	upst	Payable To Investors PayableToInvestors	90777000	usd
CY2023Q1	upst	Payable To Investors PayableToInvestors	41047000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	986394000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1000871000	usd
CY2022Q4	upst	Accrued Expenses And Other Liabilities Fair Value Disclosure AccruedExpensesAndOtherLiabilitiesFairValueDisclosure	8820000	usd
CY2023Q1	upst	Accrued Expenses And Other Liabilities Fair Value Disclosure AccruedExpensesAndOtherLiabilitiesFairValueDisclosure	7591000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	66946000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	46991000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	100787000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	99050000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1263619000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1194512000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81259676	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81259676	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82600748	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82600748	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	714871000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	798898000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42444000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171698000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	672435000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	627208000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1936054000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49991000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	313982000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117141000	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	15134000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	45315000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	959000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7132000	usd
CY2022Q1	upst	Fair Value And Other Adjustments Net FairValueAndOtherAdjustmentsNet	18021000	usd
CY2023Q1	upst	Fair Value And Other Adjustments Net FairValueAndOtherAdjustmentsNet	52397000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	-3846000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	-14214000	usd
CY2022Q1	us-gaap	Revenues Revenues	310136000	usd
CY2023Q1	us-gaap	Revenues Revenues	102927000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	133449000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	31438000	usd
CY2022Q1	upst	Customer Operations Expense CustomerOperationsExpense	48407000	usd
CY2023Q1	upst	Customer Operations Expense CustomerOperationsExpense	40590000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.58
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	110071000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43456000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52663000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	275303000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	234762000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	34833000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-131835000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2122000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2597000	usd
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	32711000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-129238000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	32692000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-129254000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	5728000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-129254000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	627208000	usd
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.58
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84230445	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81911433	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95457776	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81911433	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	807078000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5626000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	26677000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4431000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	32692000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	876504000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	672435000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1537000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	76767000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	32692000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-129254000	usd
CY2022Q1	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-18356000	usd
CY2023Q1	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-59046000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25050000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	74109000	usd
CY2022Q1	upst	Gain Loss On Loan Servicing Arrangements And Sale Of Noncontrolling Interests Net GainLossOnLoanServicingArrangementsAndSaleOfNoncontrollingInterestsNet	8705000	usd
CY2023Q1	upst	Gain Loss On Loan Servicing Arrangements And Sale Of Noncontrolling Interests Net GainLossOnLoanServicingArrangementsAndSaleOfNoncontrollingInterestsNet	3613000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2781000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6441000	usd
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	776000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	766000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	974000	usd
CY2022Q1	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	3457784000	usd
CY2023Q1	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	510003000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	3065358000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	449339000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Held For Sale ProceedsFromCollectionOfLoansHeldForSale	20328000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Loans Held For Sale ProceedsFromCollectionOfLoansHeldForSale	57949000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7287000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-306000	usd
CY2022Q1	upst	Increase Decrease In Operating Lease Liability And Right Of Use Asset IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAsset	2584000	usd
CY2023Q1	upst	Increase Decrease In Operating Lease Liability And Right Of Use Asset IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAsset	1216000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	3371000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-12170000	usd
CY2022Q1	upst	Increase Decrease In Payable To Investors IncreaseDecreaseInPayableToInvestors	32204000	usd
CY2023Q1	upst	Increase Decrease In Payable To Investors IncreaseDecreaseInPayableToInvestors	-49730000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-11093000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-19155000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-266795000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-75727000	usd
CY2022Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	0	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	46382000	usd
CY2022Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	9397000	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	24422000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2067000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	1566000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1000000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1629000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1111000	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	3658000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	4347000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5177000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25852000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	80004000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	60673000	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	6990000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	46962000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	4431000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	5728000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5626000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1537000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83071000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20971000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-178547000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-80608000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1191241000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	532467000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1012694000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	451859000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1763000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	7959000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	18000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1153000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1627000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2658000	usd
CY2022Q1	us-gaap	Transfer Of Portfolio Loans And Leases To Held For Sale1 TransferOfPortfolioLoansAndLeasesToHeldForSale1	109792000	usd
CY2023Q1	us-gaap	Transfer Of Portfolio Loans And Leases To Held For Sale1 TransferOfPortfolioLoansAndLeasesToHeldForSale1	0	usd
CY2022Q4	us-gaap	Cash Cash	422411000	usd
CY2023Q1	us-gaap	Cash Cash	386942000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	110056000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	64917000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	532467000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	451859000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. </span></div>Significant estimates and assumptions made in the accompanying condensed consolidated financial statements, which Management believes are critical in understanding and evaluating the Company’s reported financial results include: (i) fair value determinations; (ii) stock-based compensation; (iii) consolidation of VIEs; and (iv) the evaluation for impairment of goodwill and acquired intangible assets. The Company bases its estimates on various factors it believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the results of operations reported in future periods.
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	313982000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117141000	usd
CY2022Q4	upst	Trailing Fee Liabilities Fair Value Disclosure TrailingFeeLiabilitiesFairValueDisclosure	4900000	usd
CY2023Q1	upst	Trailing Fee Liabilities Fair Value Disclosure TrailingFeeLiabilitiesFairValueDisclosure	4400000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	2600000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	2600000	usd
CY2022Q1	upst	Net Gain Loss Related To Loan Servicing Rights NetGainLossRelatedToLoanServicingRights	8705000	usd
CY2023Q1	upst	Net Gain Loss Related To Loan Servicing Rights NetGainLossRelatedToLoanServicingRights	3613000	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	15134000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	45315000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	959000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7132000	usd
CY2022Q1	upst	Unrealized Gain Loss Charge Offs And Other Fair Value Adjustments Net UnrealizedGainLossChargeOffsAndOtherFairValueAdjustmentsNet	-19309000	usd
CY2023Q1	upst	Unrealized Gain Loss Charge Offs And Other Fair Value Adjustments Net UnrealizedGainLossChargeOffsAndOtherFairValueAdjustmentsNet	-44544000	usd
CY2022Q1	upst	Realized Gain Loss On Transfer Of Loans Net RealizedGainLossOnTransferOfLoansNet	1288000	usd
CY2023Q1	upst	Realized Gain Loss On Transfer Of Loans Net RealizedGainLossOnTransferOfLoansNet	-7853000	usd
CY2022Q1	upst	Fair Value And Other Adjustments Net FairValueAndOtherAdjustmentsNet	18021000	usd
CY2023Q1	upst	Fair Value And Other Adjustments Net FairValueAndOtherAdjustmentsNet	52397000	usd
CY2022Q1	upst	Interest Income And Fair Value Adjustment Net InterestIncomeAndFairValueAdjustmentNet	-3846000	usd
CY2023Q1	upst	Interest Income And Fair Value Adjustment Net InterestIncomeAndFairValueAdjustmentNet	-14214000	usd
CY2023Q1	us-gaap	Financing Receivable Threshold Period Past Due FinancingReceivableThresholdPeriodPastDue	P120D
CY2022Q4	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	12800000	usd
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	13900000	usd
CY2023Q1	upst	Risk Retention Requirement Declines RiskRetentionRequirementDeclines	0	usd
CY2023Q1	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	5000000	usd
CY2023Q1	us-gaap-supplement	Derivative Premium Paid DerivativePremiumPaid	5600000	usd
CY2023Q1	us-gaap	Financing Receivable Threshold Period Past Due FinancingReceivableThresholdPeriodPastDue	P120D
CY2023Q1	us-gaap	Financing Receivable Threshold Period Past Due Writeoff FinancingReceivableThresholdPeriodPastDueWriteoff	P120D
CY2023Q1	upst	Sensitivity Analysis Of Fair Value Assets Impact Of20 Percent Adverse Change In Expected Credit Loss Rates Average SensitivityAnalysisOfFairValueAssetsImpactOf20PercentAdverseChangeInExpectedCreditLossRatesAverage	-0.34
CY2023Q1	us-gaap	Goodwill Goodwill	67100000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1100000	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1100000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3206000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1925000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1142000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1142000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1142000	usd
CY2023Q1	upst	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	5993000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14550000	usd
CY2022Q4	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	46652000	usd
CY2023Q1	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	42943000	usd
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	36467000	usd
CY2023Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	34650000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	16740000	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	22032000	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	10002000	usd
CY2023Q1	us-gaap	Deposits Assets DepositsAssets	9839000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	6181000	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	5009000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	22678000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	19926000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	138720000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	134399000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	61327000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	69451000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17159000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22474000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	44168000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46977000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6400000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	27400000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	29900000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	23506000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	19600000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	21825000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	12824000	usd
CY2022Q4	us-gaap	Servicing Liability At Fair Value Amount ServicingLiabilityAtFairValueAmount	3968000	usd
CY2023Q1	us-gaap	Servicing Liability At Fair Value Amount ServicingLiabilityAtFairValueAmount	3142000	usd
CY2022Q4	upst	Trailing Fee Liability At Fair Value Amount TrailingFeeLiabilityAtFairValueAmount	4852000	usd
CY2023Q1	upst	Trailing Fee Liability At Fair Value Amount TrailingFeeLiabilityAtFairValueAmount	4449000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	12795000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	6976000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	66946000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	46991000	usd
CY2022Q4	upst	Long Term And Short Term Debt Gross LongTermAndShortTermDebtGross	997702000	usd
CY2023Q1	upst	Long Term And Short Term Debt Gross LongTermAndShortTermDebtGross	1011413000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	11308000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	10542000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	986394000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1000871000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	222100000	usd
CY2023Q1	upst	Long Term And Short Term Debt Maturity Remainder Of Fiscal Year LongTermAndShortTermDebtMaturityRemainderOfFiscalYear	0	usd
CY2023Q1	upst	Long Term And Short Term Debt Maturity Year One LongTermAndShortTermDebtMaturityYearOne	151733000	usd
CY2023Q1	upst	Long Term And Short Term Debt Maturity Year Two LongTermAndShortTermDebtMaturityYearTwo	198430000	usd
CY2023Q1	upst	Long Term And Short Term Debt Maturity Year Three LongTermAndShortTermDebtMaturityYearThree	661250000	usd
CY2023Q1	upst	Long Term And Short Term Debt Maturity Year Four LongTermAndShortTermDebtMaturityYearFour	0	usd
CY2023Q1	upst	Long Term And Short Term Debt Maturity After Year Four LongTermAndShortTermDebtMaturityAfterYearFour	0	usd
CY2023Q1	upst	Long Term And Short Term Debt Gross LongTermAndShortTermDebtGross	1011413000	usd
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	27666452	shares
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	31200906	shares
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	400000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12547010	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.65
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	77289000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2065794	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.23
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	331093	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.64
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	351794	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	18.81
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13929917	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.87
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	96888000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8251381	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.94
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M6D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	88402000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13881292	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	14.81
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	96844000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	105200000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4000000	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6700000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	9500000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	65400000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25050000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	74109000	usd
CY2023Q1	upst	Annual Target Bonus Opportunity Percentage Of Salary Percent AnnualTargetBonusOpportunityPercentageOfSalaryPercent	0.75
CY2023Q1	upst	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Number Of Vesting Tranches ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumberOfVestingTranches	9	vesting_tranche
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	3400000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	11426000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	17054000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	17544000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	18055000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	17745000	usd
CY2023Q1	upst	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	34816000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	116640000	usd
CY2023Q1	upst	Lessee Operating Lease Liability Tenant Improvement Receivable LesseeOperatingLeaseLiabilityTenantImprovementReceivable	2375000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15215000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	99050000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	3932000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	4038000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	866000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	976000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2063000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3665000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y29D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0385
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0006
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0001
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	32692000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-129254000	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84230445	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81911433	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11227331	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95457776	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81911433	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.58
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.58
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4804812	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24596844	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
upst-20230331_def.xml	Edgar Link	unprocessable
upst-20230331_cal.xml	Edgar Link	unprocessable
0001647639-23-000035-index-headers.html	Edgar Link	pending
0001647639-23-000035-index.html	Edgar Link	pending
0001647639-23-000035.txt	Edgar Link	pending
0001647639-23-000035-xbrl.zip	Edgar Link	pending
exhibit311q12023.htm	Edgar Link	pending
exhibit312q12023.htm	Edgar Link	pending
exhibit321q12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
upst-20230331.htm	Edgar Link	pending
upst-20230331.xsd	Edgar Link	pending
upst-20230331_g1.jpg	Edgar Link	pending
upst-20230331_lab.xml	Edgar Link	unprocessable
upst-20230331_pre.xml	Edgar Link	unprocessable
upst-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UPST
Upstart Holdings, Inc. Stock $upst

2023 Q2 Form 10-Q Financial Statement

#000164763923000035 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPST Upstart Holdings, Inc. Stock $upst

2023 Q2 Form 10-Q Financial Statement

#000164763923000035 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPST
Upstart Holdings, Inc. Stock $upst